Atlas Trials

Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

Clinical trial NCT05718609 · UNKNOWN

Trial details

NCT number
NCT05718609
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Helicobacter Pylori Infection
Start date
2023-03-01
Primary completion
2024-03-01
Enrollment
855

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.